ScholarIQanswers from OpenAlex & ORCID
Hiroyasu Esumi
ResearcherPublications, citations & collaboration network
Hiroyasu Esumi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Hiroyasu Esumi have?
ScholarIQindexed works
Hiroyasu Esumi has 392 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hiroyasu Esumi have?
ScholarIQcitation count
Hiroyasu Esumi has 17,821 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Hiroyasu Esumi?
ScholarIQh-index
Hiroyasu Esumi has an h-index of 71 in OpenAlex.
What is the i10-index of Hiroyasu Esumi?
ScholarIQi10-index
Hiroyasu Esumi has an i10-index of 232 in OpenAlex.
What is the ORCID of Hiroyasu Esumi?
ScholarIQorcid
The ORCID for Hiroyasu Esumi is on the source record.
What is the OpenAlex record for Hiroyasu Esumi?
ScholarIQopenalex
The OpenAlex for Hiroyasu Esumi is on the source record.
What are the most-cited papers on Hiroyasu Esumi?
ScholarIQmost cited works
Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome
Satoshi Fujii, Shuichi Mitsunaga, Manabu Yamazaki, Takahiro Hasebe, Genichiro Ishii, Motohiro Kojima, Taira Kinoshitá, Takashi Ueno, Hiroyasu Esumi, Atsushi Ochiai
Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis
Shigeki Umemura, Sachiyo Mimaki, Hideki Makinoshima, Satoshi Tada, Genichiro Ishii, Hironobu Ohmatsu, Seiji Niho, Kiyotaka Yoh, Shingo Matsumoto, Akiko Takahashi, Masahiro Morise, Yuka Nakamura, Atsushi Ochiai, Kanji Nagai, Reika Iwakawa, Takashi Kohno, Jun Yokota, Yuichiro Ohe, Hiroyasu Esumi, Katsuya Tsuchihara, Kōichi Goto
Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
Hideki Makinoshima, Masahiro Takita, Shingo Matsumoto, Atsushi Yagishita, Satoshi Owada, Hiroyasu Esumi, Katsuya Tsuchihara
Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma
Hideki Makinoshima, Masahiro Takita, Koichi Saruwatari, Shigeki Umemura, Yuuki Obata, Genichiro Ishii, Shingo Matsumoto, Eri Sugiyama, Atsushi Ochiai, Ryo Abe, Kōichi Goto, Hiroyasu Esumi, Katsuya Tsuchihara